EZH2 and small cell lung carcinoma: The gene body of SLFN11 is also targeted by the histone modifier EZH2 (enhancer of zeste homology 2) during acquired chemoresistance in small-cell lung cancer (SCLC) cells, which increases H3K27me3 and local chromatin condensation70.